Skip to content

    RIGEL PHARMACEUTICALS (RIGL) stock price & financials

    View RIGL earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+17.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $55.31M
    $57.60M
    $53.33M
    $101.69M
    $69.46M
    +25.6%
    $69.80M
    +21.2%
    $58.82M
    +10.3%
    $78.70M
    -22.6%
    Stable
    Operating Profit
    $14.06M
    $16.66M
    $12.77M
    $61.10M
    $28.42M
    +102.2%
    $23.17M
    +39.1%
    $11.88M
    -7.0%
    $23.57M
    -61.4%
    Weakening
    Net Profit
    $12.42M
    $14.34M
    $11.45M
    $59.61M
    $27.90M
    +124.6%
    $268.06M
    +1769.2%
    $8.65M
    -24.4%
    $17.29M
    -71.0%
    Strengthening
    EPS
    $0.71
    $0.64
    $3.33
    $1.55
    +118.3%
    $0.47
    -26.6%
    $0.93
    -72.1%
    Weakening
    Other Income
    Interest
    $2.06M
    $1.96M
    $1.85M
    $1.87M
    $1.89M
    -8.1%
    $1.70M
    -13.1%
    $1.43M
    -22.7%
    $779.0K
    -58.4%
    Weakening
    Depreciation
    Profit before Tax
    $12.42M
    $15.22M
    $11.51M
    $59.98M
    $27.62M
    +122.4%
    $22.71M
    +49.2%
    $11.66M
    +1.3%
    $23.59M
    -60.7%
    Weakening
    MarginsOPM
    25.4%
    28.9%
    23.9%
    60.1%
    40.9%
    +61.0%
    33.2%
    +14.8%
    20.2%
    -15.6%
    29.9%
    -50.2%
    Weakening
    Tax
    0.0%
    5.8%
    0.6%
    0.6%
    -1.0%
    -1080.2%
    -18756.0%
    25.8%
    +4500.0%
    26.7%
    +4204.8%
    Weakening
    ReturnsROIC
    -1.2%
    -1.4%
    -1.1%
    -6.0%
    -2.8%
    -124.6%
    -26.9%
    -1769.2%
    -0.9%
    +24.4%
    -1.7%
    +71.0%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$76.32M$22.52M$30.37M$18.89M$24.46M$32.79M$56.75M$40.58M$60.82M
    Short-Term Investments
    Total Current Assets$136.99M$119.00M$88.98M$154.47M$115.90M$99.27M$135.10M$240.17M$185.53M
    Net PP&E$1.39M$27.87M$20.57M$11.89M$2.79M$1.03M$338.0K$950.0K$647.0K
    Goodwill
    Intangibles$14.95M$13.88M$27.10M$24.75M$93.88M
    Total Assets$139.11M$147.57M$110.38M$167.33M$134.28M$117.22M$163.98M$513.59M$521.07M
    LiabilitiesTotal Current Liabilities$27.73M$58.21M$40.84M$63.55M$65.21M$53.27M$63.30M$99.24M$95.59M
    Short-Term Debt
    Long-Term Debt$10.00M$20.00M$20.00M$40.00M$60.00M$60.00M$52.50M
    Long-Term Leases$19.23M$10.65M$759.0K$972.0K$285.0K$0$395.0K$58.0K
    Total Liabilities$29.23M$93.75M$76.35M$136.95M$147.90M$145.87M$160.69M$122.11M$95.64M
    EquityCommon Stock & APIC$167.0K$168.0K$169.0K$172.0K$174.0K$17.0K$18.0K$18.0K$18.0K
    Retained Earnings-$1.21B-$1.28B-$1.31B-$1.32B-$1.38B-$1.41B-$1.39B-$1.02B-$997.10M
    Total Equity$109.88M$53.81M$34.03M$30.37M-$13.62M-$28.64M$3.29M$391.48M$425.42M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$58.83M-$41.51M-$52.19M$5.88M-$73.76M-$5.74M$31.47M$75.66M$79.39M
    Cash from Investing$24.96M-$23.66M$47.47M-$80.04M$72.78M-$4.30M$4.13M-$92.36M-$49.06M
    Cash from Financing$71.89M$11.37M$12.57M$62.67M$6.55M$18.37M-$11.64M$601.0K-$22.92M
    SummaryCapital Expenditure-$1.11M-$1.46M-$1.26M-$627.0K-$450.0K
    Free Cash Flow-$59.93M-$42.97M-$53.45M$5.25M-$74.21M
    FCF Margin-134.7%-72.5%-49.2%3.5%-61.7%

    Ratios